Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신윤용 | * |
dc.contributor.author | 김대기 | * |
dc.date.accessioned | 2016-08-28T11:08:01Z | - |
dc.date.available | 2016-08-28T11:08:01Z | - |
dc.date.issued | 2014 | * |
dc.identifier.issn | 1464-3391 | * |
dc.identifier.other | OAK-11305 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/227729 | - |
dc.description.abstract | ALK5 inhibitor; Cancer; Cell-based luciferase reporter assay; Docking; Fibrosis; Kinase assay; TGF-β | * |
dc.language | English | * |
dc.publisher | Elsevier Ltd | * |
dc.title | 4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type i receptor kinase | * |
dc.type | Article | * |
dc.relation.issue | 9 | * |
dc.relation.volume | 22 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 2724 | * |
dc.relation.lastpage | 2732 | * |
dc.relation.journaltitle | Bioorganic and Medicinal Chemistry | * |
dc.identifier.doi | 10.1016/j.bmc.2014.03.022 | * |
dc.identifier.wosid | WOS:000334744100016 | * |
dc.identifier.scopusid | 2-s2.0-84899455861 | * |
dc.author.google | Jin C.H. | * |
dc.author.google | Krishnaiah M. | * |
dc.author.google | Sreenu D. | * |
dc.author.google | Subrahmanyam V.B. | * |
dc.author.google | Park H.-J. | * |
dc.author.google | Park S.-J. | * |
dc.author.google | Sheen Y.Y. | * |
dc.author.google | Kim D.-K. | * |
dc.contributor.scopusid | 신윤용(6603872711) | * |
dc.contributor.scopusid | 김대기(35083694200) | * |
dc.date.modifydate | 20240118164500 | * |